LIMK1 and hepatocellular carcinoma: The role of LIMK1 in HCC has been discovered recently, and studies have shown that exo-miR-374c-5p inhibits EMT by targeting the LIMK1-Wnt/β-catenin signaling to suppress HCC metastasis [217], while lncRNA H19 upregulates LIMK1 by sponging miR-520a-3p to promote HCC progression [218].